hydroxyproline has been researched along with 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin d3 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harada, M; Higuchi, S; Ikekawa, N; Ikemoto, Y; Kozuka, H; Miyahara, T; Miyata, M; Okayachi, H; Otomo, S; Tomita, I | 1 |
| Chiba, H; Higuchi, S; Iba, K; Kozakai, A; Miyahara, T; Nemoto, N; Osahune, N; Sakuma, T; Sawada, N; Simoura, T; Takamura, T; Uchida, Y; Yamazaki, R | 1 |
2 other study(ies) available for hydroxyproline and 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin d3
| Article | Year |
|---|---|
Effects on cultured neonatal mouse calvaria of 1 alpha,25-dihydroxyvitamin D3, 26,26,26,27,27,27-hexafluoro-1 alpha,25-dihydroxyvitamin D3 and 26,26,26,27,27,27-hexafluoro-1 alpha,23S,25-trihydroxyvitamin D3.
Topics: Acid Phosphatase; Animals; Bone and Bones; Bone Resorption; Calcitriol; Calcium; Cells, Cultured; Dihydroxycholecalciferols; Hydroxyproline; Mice; Organ Culture Techniques; Osteoclasts; Rats | 1992 |
A highly potent 26,27-Hexafluoro-1a,25-dihydroxyvitamin D3 on calcification in SV40-transformed human fetal osteoblastic cells.
Topics: Alkaline Phosphatase; Blotting, Northern; Calcification, Physiologic; Calcitriol; Cell Line, Transformed; Cell Transformation, Viral; Dose-Response Relationship, Drug; Fetus; Humans; Hydroxyproline; Osteoblasts; Osteocalcin; Osteopontin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sialoglycoproteins; Staining and Labeling | 2002 |